ANIO Distinguished Leader Award this year goes to Dr Reshma Kewalramani
Reshma Kewalramani, M.D., FASN, is the Chief Executive Officer & President at Vertex Pharmaceuticals, a Fortune 500, global biotechnology company. She trained in internal medicine and nephrology before entering the biopharmaceutical industry, where she has dedicated her career to discovering and developing new medicines. She joined Vertex in 2017, served as Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs and became CEO in 2020.
Today, Vertex has multiple approved therapies that treat the underlying causes of cystic fibrosis (CF), sickle cell disease, transfusion-dependent beta thalassemia and acute pain. In addition, Vertex is advancing a clinical-stage pipeline that represents best in class and/or first in class approaches in multiple disease areas, including CF, pain, type 1 diabetes, myotonic dystrophy type 1 and select renal diseases, across multiple modalities including small molecule, mRNA, biologics, cell and gene therapies. Continuing the tradition of excellence in the workplace, under Dr. Kewalramani’s leadership as CEO, Vertex has consistently been recognized as a best place to work, including by Science magazine, The Boston Globe and Fortune.
Dr. Kewalramani completed her internship and residency in internal medicine at the Massachusetts General Hospital, and her fellowship in nephrology at the Massachusetts General Hospital and Brigham and Women’s Hospital combined program. She received her medical degree, with honors, from the seven-year medicine program at the Boston University Chobanian & Avedisian School of Medicine and is a Fellow of the American Society of Nephrology. She is an alumna of the Harvard Business School, having completed the General Management Program.
Dr. Kewalramani has received a number of distinguished honors and awards for her leadership and contributions to science and innovation. She has been named to the TIME 100 Most Influential People in the World list, the TIME 100 Health list, and is one of Fortune’s Most Powerful People, a Changemaker by CNBC, one of Boston Business Journal’s “Power 50,” one of Boston magazine’s most influential Bostonians, a top CEO by Barron’s, and one of Business Insider’s “10 People Transforming Healthcare.” She has received the Harvard Business School Alumni Achievement Award, the Distinguished Alumni Award from the Boston University School of Medicine, and the International Institute of New England Golden Door Award, among others.
Please congratulate Dr Kewalramani in this special award in 2026
Come celebrate with us on Oct 23nd at ASN Kidney Week 2026.
Categories: Announcements, ASN event, award
American Nephrologists of Indian Origin 
Leave a comment